Original Literature | Model OverView |
---|---|
Publication
Title
Convergence of the NF-kappaB and IRF pathways in the regulation of the innateantiviral response.
Affiliation
Lady Davis Institute for Medical Research - Jewish General Hospital, Departmentsof Microbiology & Immunology, Medicine and Oncology, McGill University,Montreal, Canada H3T 1E2. john.hiscott@mcgill.ca
Abstract
The type I interferon (IFN) alpha and beta promoters have been a leadingparadigm of virus-activated transcriptional regulation for more than twodecades, and have contributed substantially to our understanding ofvirus-inducible gene regulation, the coordinated activities of NF-kappaB and IRFtranscription factors, the temporal and spatial recruitment of co-activators tothe enhanceosome, and signaling pathways that trigger the innate antiviralresponse. In 2003, the ISICR Milstein Award was presented to John Hiscott ofMcGill University and Tom Maniatis of Harvard University for their ongoingresearch describing the mechanisms of regulation of type 1 interferon genes andspecifically for the identification of key signaling kinases involved inphosphorylation of the transcription factors IRF-3 and IRF-7. The specific rolesplayed by IRFs and the IKK-related kinases TBK1 and IKKvarepsilon are nowrecognized within the broader framework of TLR and RIG-I signaling pathways.This review summarizes the unique features of the IKK-related kinases and offersa summary of recent advances in the regulation of the early host response tovirus infection.
PMID
17706453
|
Entity
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m5
10
infinite
0
TRANSPATH | MO000000058 |
--
IKK-i
--
MO000016608
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1599
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000016608 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
PolyI:C:IFIH1
--
e10
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m11
0
infinite
0
--
DDX58:dsRNA:Efp
--
e11
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m12
0
infinite
0
--
DDX58 {ub}:dsRNA:Efp
--
e12
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m13
0
infinite
0
--
DDX58{ub}:dsRNA:Efp:MAVS
--
e13
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m14
0
infinite
0
--
DDX58{ub}:dsRNA:Efp:MAVS:TRAF3
--
e14
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m15
0
infinite
0
--
TANK:TRAF2:TBK1:IKK-i
--
e15
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m16
0
infinite
0
--
NAP1
--
e16
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m17
0
infinite
0
--
NAP1:IKK-i:TBK1
--
e17
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m18
0
infinite
0
--
TANK:TRAF2
--
e18
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m19
0
infinite
0
--
TANK{p}:TRAF2:TBK1:IKK-i
--
e19
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m20
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
TANK{p}:TBK1:IKK-i
--
e20
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m21
0
infinite
0
--
DDX58{ub}:dsRNA:Efp:MAVS:TRAF6
--
e21
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m22
0
infinite
0
--
IKK:TANK{p}:TBK1:Ikk-i
--
e22
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m23
0
infinite
0
--
DDX58{ub}:dsRNA:Efp:MAVS:TRAF3:IKK:TANK{p}:TBK1:IKK-i
--
e23
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m24
0
infinite
0
--
DDX58{ub}:dsRNA:Efp:MAVS:TRAF3:IKK:TANK{p}:TBK1:IKK-i{active}
--
e24
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m25
0
infinite
0
--
IRF-3{p} dimer
--
e27
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m28
0
infinite
0
--
IRF-3{p} dimer
--
e28
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m29
0
infinite
0
--
IRF-3{p}dimer:CBP
--
e29
cso30:c:Complex
cso30:i:CC_NuclearLumen
--
csml-variable:Double
m30
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
DDX58{ub}:dsRNA:Efp:MAVS:TRAF6:IKK:TANK{p}:TBK1:IKK-i
--
e30
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m31
0
infinite
0
--
DDX58{ub}:dsRNA:Efp:MAVS:TRAF6:IKK{active}:TANK{p}:TBK1:IKK-i
--
e31
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m32
0
infinite
0
--
NF-KappaB:IkappaB-alpha
--
e32
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m33
0
infinite
0
--
IKappaB-alpha{p}
--
e33
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m34
0
infinite
0
--
proinflammatory genes
--
e34
cso30:c:mRNA
cso30:i:CC_NuclearLumen
--
--
csml-variable:Double
m35
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
DDX58:dsRNA
--
e5
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m6
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
PolyI:C
--
e6
cso30:c:mRNA
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m10
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m119368*m41844*0.1
nodelay
--
0
PMID: 17706453 Furthermore, MDA5 and RIG-I recognize different types of dsRNAs: MDA5 recognizes poly(I:C), and RIG-I detects in vitro transcribed dsRNAs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c34 : 1
m16*0.1
nodelay
--
0
PMID: 17706543,10759890 Overexpression of IKKvar epsilon or TBK-1 induces phosphorylation of I-TRAF/TANK, which results in its dissociation from TRAF2 and subsequent activation of NF-¦ÊB transcription through the classical IKK pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c36 : 1
stoichiometry:c37 : 1
m20*0.1
nodelay
--
0
PMID: 17706543,10759890 Overexpression of IKKvar epsilon or TBK-1 induces phosphorylation of I-TRAF/TANK, which results in its dissociation from TRAF2 and subsequent activation of NF-¦ÊB transcription through the classical IKK pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c43 : 1
stoichiometry:c39 : 1
m14*m183*0.1
nodelay
--
0
PMID: 17706453 TRAF3 and/or TRAF6 are also recruited to MAVS through a direct interaction with a TRAF-interaction motif within MAVS.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m207*m21*0.1
nodelay
--
0
PMID: 17706542 NEMO association with the adapter TANK facilitates the recruitment of TBK1 and IKKvar epsilon to the MAVS-TRAF complex and results in activation of TBK1 and IKKvar epsilon PMID: 17706453,12133833,17468758 Physical association between TANK and NEMO suggest that the canonical IKK complex and the IKK-related kinases may exist as a physically associated signaling complex responsible for phosphorylation of additional transcription factors PMID: 17706453 NEMO acts downstream of MAVS and RIG-I, and physically interacts with the TANK adapter to mediate recruitment of TBK1 and IKKvar epsilon to the RIG-I?MAVS complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c45 : 1
stoichiometry:c46 : 1
m15*m23*0.1
nodelay
--
0
PMID: 17706542 NEMO association with the adapter TANK facilitates the recruitment of TBK1 and IKKvar epsilon to the MAVS-TRAF complex and results in activation of TBK1 and IKK epsilon
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c47 : 1
stoichiometry:c48 : 1
m24*0.1
nodelay
--
0
PMID: 17706542 NEMO association with the adapter TANK facilitates the recruitment of TBK1 and IKKvar epsilon to the MAVS-TRAF complex and results in activation of TBK1 and IKK epsilon
p17
p17
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c50 : 1
stoichiometry:c51 : 1
m25*m977*0.1
nodelay
--
0
PMID: 17706453,15367631,14679297,16914100 Both TBK-1 and IKKvar epsilon directly phosphorylate IRF-3 and IRF-7 at key resides within their C-terminal signal-responsive domain in vitro and both kinases target identical serine residues PMID: 17706543 Activated TBK1 and IKKvar epsilon phosphorylate IRF3 and IRF7, which provoke IFN expression and development of an antiviral state.
p17
p18
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c52 : 1
stoichiometry:c53 : 1
stoichiometry:c54 : 1
m25*m980*0.1
nodelay
--
0
PMID: 17706453,15367631,14679297,16914100 Both TBK-1 and IKKvar epsilon directly phosphorylate IRF-3 and IRF-7 at key resides within their C-terminal signal-responsive domain in vitro and both kinases target identical serine residues PMID: 17706543 Activated TBK1 and IKKvar epsilon phosphorylate IRF3 and IRF7, which provoke IFN expression and development of an antiviral state.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c56 : 1
m26*0.1
nodelay
--
0
PMID: 17706453,10082512 Based on available biochemical data, a model for IRF-3 activation proposes that C-terminal phosphorylation induces a conformational change in IRF-3 that allows homo- and hetero-dimerization, nuclear localization, and association with the co-activator CBP/p300
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m10*m76904*0.1
nodelay
--
0
PMID: 17706453 Furthermore, MDA5 and RIG-I recognize different types of dsRNAs: MDA5 recognizes poly(I:C), and RIG-I detects in vitro transcribed dsRNAs.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c58 : 1
m28*0.1
nodelay
--
0
PMID: 17706453,10082512 Based on available biochemical data, a model for IRF-3 activation proposes that C-terminal phosphorylation induces a conformational change in IRF-3 that allows homo- and hetero-dimerization, nuclear localization, and association with the co-activator CBP/p300
p21
p21
cso30:i:ME_Binding
cso30:i:CC_NuclearChromosome
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c59 : 1
stoichiometry:c60 : 1
stoichiometry:c61 : 1
m29*m72733*0.1
nodelay
--
0
PMID: 17706453,10082512 Based on available biochemical data, a model for IRF-3 activation proposes that C-terminal phosphorylation induces a conformational change in IRF-3 that allows homo- and hetero-dimerization, nuclear localization, and association with the co-activator CBP/p300
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c63 : 1
m30*0.1
nodelay
--
0
PMID: 17706453,17395583 Inactive IRF-3 constitutively shuttles into and out of the nucleus, whereas phosphorylation-dependent association with CBP/p300 retains IRF-3 in the nucleus and induces transcription of IFN-¦Â and other genes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c65 : 1
stoichiometry:c66 : 1
m22*m23*0.1
nodelay
--
0
PMID: 17706542 NEMO association with the adapter TANK facilitates the recruitment of TBK1 and IKKvar epsilon to the MAVS-TRAF complex and results in activation of TBK1 and IKK epsilon
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c68 : 1
m31*0.1
nodelay
--
0
p25
p25
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c70 : 1
stoichiometry:c71 : 1
stoichiometry:c72 : 1
m33*m32*0.1
nodelay
--
0
PMID: 17706453,17047224 Inducible activation of canonical NF-¦ÊB signaling requires phosphorylation of the I¦ÊB inhibitor by the 700?900 kDa multi-protein canonical IKK complex composed of two catalytic kinase subunits, IKKgreek small letter alpha and IKK¦Â, and a non-enzymatic regulatory subunit NF-¦ÊB Essential Modulator (NEMO) or IKK¦Ã PMID: 17706543 MAVS-TRAF complexes also activate the canonical NEMO-IKKalpha-IKK¦Â complex which phosphorylates the inhibitory subunit I¦ÊBalpha, resulting in the release of NF-¦ÊB and activation of proinflammatory gene transcription.
p26
p26
cso30:i:ME_GeneExpression
cso30:i:CC_NuclearLumen
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c74 : 1
m5*0.1
nodelay
--
0
PMID: 17706543 MAVS-TRAF complexes also activate the canonical NEMO-IKKalpha-IKK¦Â complex which phosphorylates the inhibitory subunit I¦ÊBalpha, resulting in the release of NF-¦ÊB and activation of proinflammatory gene transcription.
p27
p27
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c76 : 1
stoichiometry:c77 : 1
m1599*m1357*0.1
nodelay
--
0
PMID: 17706453 The structural and functional consequences of this phosphorylation remain to be determined, although it is suggested that IKKvar epsilon-dependent phosphorylation of STAT1 appears to guide the transcriptional machinery to a subset of ISGs required for the direct antiviral response, whereas the IKK-independent genes may function in regulating the IFN signaling required for integration of innate and adaptive immune systems.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m6*m63891*0.1
nodelay
--
0
PMID:17706453 TRIM25 alpha contains a RING-finger domain, a B box/coiled-coil domain and a SPRY domain and induces robust ubiquitination of the CARD domains of RIG-I. PMID: 17706453 The carboxy-terminal SPRY domain of TRIM25 alpha interacts with the N-terminal CARDs of RIG-I; this interaction effectively delivers the Lys 63-linked ubiquitin moiety to the N-terminal CARDs of RIG-I, resulting in a marked increase in RIG-I downstream signaling activity.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
m12*0.1
nodelay
--
0
PMID: 17706453 The carboxy-terminal SPRY domain of TRIM25 alpha interacts with the N-terminal CARDs of RIG-I; this interaction effectively delivers the Lys 63-linked ubiquitin moiety to the N-terminal CARDs of RIG-I, resulting in a marked increase in RIG-I downstream signaling activity.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c13 : 1
stoichiometry:c14 : 1
m68199*m13*0.1
nodelay
--
0
PMID: 17706453,16785313,16125763,16153868,16177806 The adaptor molecule providing a link between RIG-I sensing of incoming viral RNA and downstream activation events was independently elucidated as mitochondrial antiviral signaling adapter (MAVS), also known as (IPS-1/VISA/Cardif) PMID: 17706453,16177806 MAVS interacts with RIG-I and recruits IKKvar epsilon through its C-terminal region; knockdown by siRNA inhibited RIG-I-dependent antiviral responses
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c16 : 1
stoichiometry:c17 : 1
m14*m1872*0.1
nodelay
--
0
PMID: 17706453 TRAF3 and/or TRAF6 are also recruited to MAVS through a direct interaction with a TRAF-interaction motif within MAVS.
p7
p7
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c18 : 1
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m181*m182*m1593*0.1
nodelay
--
0
PMID: 17706453,17047224 Inducible activation of canonical NF-¦ÊB signaling requires phosphorylation of the I¦ÊB inhibitor by the 700?900 kDa multi-protein canonical IKK complex composed of two catalytic kinase subunits, IKKgreek small letter alpha and IKK¦Â, and a non-enzymatic regulatory subunit NF-¦ÊB Essential Modulator (NEMO) or IKK¦Ã
p8
p8
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c32 : 1
stoichiometry:c25 : 1
m1599*m3902*m19*0.1
nodelay
--
0
PMID: 17706453,10759890 Both TBK-1 and IKK epsilon interact with the TNF-receptor-associated factor (TRAF)-interacting protein/TRAF family member-associated NF-¦ÊB activator (I-TRAF/TANK) protein, a modulator of TNF alpha-induced NF-¦ÊB activation
p9
p9
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c27 : 1
stoichiometry:c28 : 1
stoichiometry:c29 : 1
m1599*m17*m3902*0.1
nodelay
--
0
PMID: 17706543,14560022 Associated Protein 1 (NAP1), a homologue of I-TRAF/TANK, has also been shown to directly interact with TBK-1 and IKK epsilon
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--